Diego Novick

4.7k total citations · 1 hit paper
128 papers, 3.6k citations indexed

About

Diego Novick is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Diego Novick has authored 128 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Psychiatry and Mental health, 38 papers in Pharmacology and 24 papers in Clinical Psychology. Recurrent topics in Diego Novick's work include Schizophrenia research and treatment (61 papers), Bipolar Disorder and Treatment (38 papers) and Treatment of Major Depression (31 papers). Diego Novick is often cited by papers focused on Schizophrenia research and treatment (61 papers), Bipolar Disorder and Treatment (38 papers) and Treatment of Major Depression (31 papers). Diego Novick collaborates with scholars based in United Kingdom, Spain and United States. Diego Novick's co-authors include Josep María Haro, David L. Suarez, Catherine Reed, Jihyung Hong, Jordi Alonso, Peter Haddad, William Montgomery, Regina Dittmann, Dieter Naber and Peter B. Jones and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Spine.

In The Last Decade

Diego Novick

125 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia

2003 511 citations Josep María Haro, Diego Novick et al. Acta Psychiatrica Scandinavica profile →

Peers

Countries citing papers authored by Diego Novick

Since Specialization

Citations

This map shows the geographic impact of Diego Novick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Novick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Novick more than expected).

Fields of papers citing papers by Diego Novick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Novick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Novick. The network helps show where Diego Novick may publish in the future.

Co-authorship network of co-authors of Diego Novick

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Novick. A scholar is included among the top collaborators of Diego Novick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Novick. Diego Novick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A systematic literature review of prognostic factors in patients with HR+/HER2− advanced breast cancer in Japan 2021 ·Japanese Journal of Clinical Oncology ·Masaya Hattori, Diego Novick, Kana Takaura, Yoshinori Tanizawa, Tsutomu Kawaguchi, Josep María Haro, (unknown), Akira Ōnishi, Hiroji Iwata	4
2	Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea 2021 ·Drugs - Real World Outcomes ·Diego Novick, Jae Min Cho, Sam Colman, Ágota Szende	1
3	PCN107 Real World Chart Review of Treatment Patterns and Health Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib in Korea 2020 ·Value in Health Regional Issues ·Diego Novick, (unknown), (unknown), Sam Colman, Ágota Szende	0
4	Retrospective analysis of patients with locally advanced or metastatic gastric cancer in Argentina 2019 ·SHILAP Revista de lepidopterología ·Diego Novick, Guillermo Méndez, Marcela Carballido, (unknown), Juan Manuel O’Connor, (unknown), (unknown), Sara Siddi, Demián Rodante, María Victoria Moneta, Josep María Haro	1
5	Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline 2018 ·Neuropsychiatric Disease and Treatment ·Jia Huang, Yun Wang, Jun Chen, Yanlei Zhang, Zhengqiang Yuan, Yue Li, Josep María Haro, María Victoria Moneta, Diego Novick, Yiru Fang	6
6	Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study 2017 ·Patient Preference and Adherence ·Diego Novick, William Montgomery, (unknown), María Victoria Moneta, Héctor Dueñas, Josep María Haro	24
7	Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder 2017 ·Patient Preference and Adherence ·Diego Novick, William Montgomery, Tamás Treuer, Ai Koyanagi, Jaume Aguado, Susanne A. Kraemer, Josep María Haro	10
8	Impact of pain and remission in the functioning of patients with depression in Mainland China, Taiwan, and Hong Kong 2017 ·Asia-Pacific Psychiatry ·Diego Novick, Qiang Shi, Yue Li, María Victoria Moneta, Sara Siddi, Josep María Haro	4
9	Sex differences in the course of schizophrenia across diverse regions of the world 2016 ·Neuropsychiatric Disease and Treatment ·Diego Novick, William Montgomery, Tamás Treuer, María Victoria Moneta, Josep María Haro	30
10	Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer Patients in Brazil 2016 ·Value in Health ·Diego Novick, (unknown), (unknown), (unknown), (unknown), (unknown), G. Julian	1
11	Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder? 2015 ·Asia-Pacific Psychiatry ·Diego Novick, William Montgomery, Jaume Aguado, Xiaomei Peng, Roberto Brugnoli, Josep María Haro	19
12	Relationship of Insight with Medication Adherence and the Impact on Outcomes in Patients with Schizophrenia and Bipolar Disorder: Results From A 1-Year European Outpatient Observational Study 2014 ·Value in Health ·Diego Novick, William Montgomery, Tamás Treuer, Jaume Aguado, Susanne A. Kraemer, Josep María Haro	7
13	Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetine 2013 ·Journal of Medical Economics ·Zhanglin Lin Cui, Douglas E. Faries, Wei Shen, Stephen L. Able, Diego Novick	1
14	Utilization of duloxetine and celecoxib in osteoarthritis patients 2013 ·Current Medical Research and Opinion ·Xiaomei Peng, Ning Wu, Shih‐Yin Chen, (unknown), J. Scott Andrews, Diego Novick	4
15	MA3 Comparative Outcomes of Fibromyalgia Patients Who Initiated Duloxetine or Pregabalin: Medication Adherence and Direct Medical Costs 2012 ·Value in Health ·(unknown), (unknown), (unknown), Diego Novick, Douglas E. Faries, J. Scott Andrews, Anjui Wu, Madelaine M. Wohlreich	1
16	Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients* 2009 ·International Journal of Clinical Practice ·J. Karagianis, Diego Novick, Ján Pečeňák, Josep María Haro, Martín Dossenbach, Tamás Treuer, William Montgomery, Richard Walton, (unknown)	54
17	Incidence and characteristics of remission in schizophrenic patients: analysis of the results of the three-year SOHO study in Italy (Schizophrenia Outpatients Health Outcomes) 2008 ·Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology ·(unknown), Diego Novick, Josep María Haro, David L. Suarez, Alessandro Rossi	1
18	Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study 2008 ·Journal of Psychiatric Research ·Josep María Haro, Diego Novick, David L. Suarez, Mercedes Roca	31
19	Rates and predictors of remission and recovery during 3 years in 392 never‐treated patients with schizophrenia 2008 ·Acta Psychiatrica Scandinavica ·Martin Lambert, Dieter Naber, Alexander Schacht, Todd H. Wagner, (unknown), Anne Karow, Christian G. Huber, David L. Suarez, Josep María Haro, Diego Novick, Regina Dittmann, Benno G. Schimmelmann	121
20	Effectiveness of antipsychotic treatment for schizophrenia: 6‐month results of the Pan‐European Schizophrenia Outpatient Health Outcomes (SOHO) study 2004 ·Acta Psychiatrica Scandinavica ·Josep María Haro, E.T. Edgell, Diego Novick, Jordi Alonso, (unknown), Peter B. Jones, (unknown), Alan Breier, (unknown)	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact